Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
Journal: The Journal of allergy and clinical immunology
Published: September 03, 2021
Changes in Neutrophil-Lymphocyte or Platelet-Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis.
Journal: Journal of clinical medicine
Published: January 06, 2021
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.
Journal: Respiratory research
Published: November 18, 2019
Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
Journal: Chronic respiratory disease
Published: September 28, 2019
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
Journal: Respiratory medicine
Published: November 02, 2018
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials.
Journal: BMJ open respiratory research
Published: June 06, 2018
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Pulmonary therapy
Published: February 28, 2018
Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017.
Journal: The World Allergy Organization journal
Published: February 15, 2018
Effect of pirfenidone on gastric emptying in a rat model.
Journal: Pulmonary pharmacology & therapeutics
Published: January 23, 2018
Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: August 29, 2017
Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 16, 2017
Last Updated: 09/26/2026